📚 My “Noon Reset Protocol” that saved my life :
Who am I?
I’m a regular 65-year-old guy who almost died from an aneurysm caused by high cholesterol 8 years ago. Since then, I’ve learned everything I could about nutrition and health. I changed my eating habits, my exercise routine and my sleep habits, and today my blood test results are nearly perfect, without any medication. I share what I’ve learned.
——-
Alzheimer’s blood tests can reveal biology 20 years early — but they can’t give you a personal countdown.
What the FDA-cleared P-tau-217 test, APOE4, and the FINGER trial really change after 50.
Measurements of P-tau-217 and the amyloid-beta 42 ratio can detect Alzheimer-related biology roughly 15–20 years before memory symptoms — yet the same blood draw means different things in a symptomatic 62-year-old versus a healthy 50-year-old. This video explains how the FDA-cleared test (approved May 2025 for adults 55+ with cognitive decline) performs, why false positives rise when you screen healthy people, and what lecanemab and donanemab actually offer: about 27% slower decline in trials, balanced against ARIA brain-swelling risks. It also untangles APOE4’s 12–15x risk figure, the Lancet Commission’s “45% preventable” estimate, the Finnish FINGER and US POINTER prevention trials, and whether sleep truly “flushes” the brain. The takeaway: early detection matters only when it changes care — and the real breakthrough is an earlier route to useful action.
Chapters:
00:00 – Alzheimer’s in your blood: 20 years early?
00:55 – Why the warning window shrinks with age
01:51 – Why a normal memory score hides amyloid
02:57 – A useful signal — but not a complete answer
04:08 – The 91.7% result that can still mislead
05:47 – The hard numbers behind two Alzheimer’s drugs
07:16 – ARIA: the swelling risk hidden in treatment
08:03 – Why early diagnosis isn’t a 20-year head start
08:50 – APOE4: 12–15x risk, but not destiny
09:36 – Why “tripled risk” is an incomplete equation
10:24 – When two APOE4 copies change your decision
11:46 – The symptoms that justify a full evaluation
12:35 – Sudden confusion: emergency, not Alzheimer’s
14:02 – Does deep sleep really flush the brain?
15:01 – The mouse study that says the opposite
16:19 – 45% of dementia “preventable”? The catch
17:24 – Why cholesterol matters — but isn’t the cause
18:11 – Hearing loss: a hidden driver of decline
19:11 – What 150 minutes of exercise really protects
19:45 – Finland’s FINGER trial: a bundle, not a pill
20:19 – The 25% improvement — and its two-year limit
21:56 – The US POINTER trial: does structure beat advice?
23:15 – Use the silent years: the real breakthrough
#Alzheimers #Dementia #BrainHealth #APOE4 #BloodBiomarkers #Neuroscience
source